TANZINI, UMBERTO
 Distribuzione geografica
Continente #
EU - Europa 169
AS - Asia 129
NA - Nord America 107
SA - Sud America 11
AF - Africa 2
Totale 418
Nazione #
RU - Federazione Russa 98
US - Stati Uniti d'America 98
SG - Singapore 53
IT - Italia 40
CN - Cina 34
VN - Vietnam 16
HK - Hong Kong 11
BR - Brasile 10
IN - India 8
NL - Olanda 6
CA - Canada 5
ES - Italia 5
FR - Francia 5
GB - Regno Unito 5
MX - Messico 4
TR - Turchia 4
DE - Germania 3
PL - Polonia 3
CH - Svizzera 2
AR - Argentina 1
FI - Finlandia 1
ID - Indonesia 1
LT - Lituania 1
PK - Pakistan 1
TN - Tunisia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 418
Città #
Singapore 39
Ashburn 22
Moscow 16
Milan 12
Hong Kong 11
San Jose 11
Cesano Boscone 9
Dallas 9
Ho Chi Minh City 7
Boardman 4
Chennai 4
Hefei 4
New York 4
Santa Clara 4
Shanghai 4
Shenzhen 4
São Paulo 4
Council Bluffs 3
Hanoi 3
Lauterbourg 3
Los Angeles 3
Toronto 3
Amsterdam 2
Beijing 2
Biên Hòa 2
Boston 2
Cagliari 2
City of London 2
Denver 2
Florence 2
Istanbul 2
Naples 2
Orem 2
Poplar 2
Querétaro 2
Rome 2
Warsaw 2
Zurich 2
Ankara 1
Bragança Paulista 1
Brescia 1
Brooklyn 1
Carapicuíba 1
Carney 1
Chandigarh 1
Charata 1
Chicago 1
Cleveland 1
Da Nang 1
Dalmine 1
Fortaleza 1
Frankfurt am Main 1
Greenville 1
Greer 1
Haiphong 1
Helena 1
Houston 1
Islamabad 1
Jackson 1
Jakarta 1
Jiaxing 1
Johannesburg 1
João Monlevade 1
Jundiaí 1
Kayapınar 1
Las Vegas 1
Maceió 1
Mestre 1
Mexico City 1
Miami 1
Montreal 1
Mumbai 1
Noida 1
Nuremberg 1
Oklahoma City 1
Phú Thọ 1
Segrate 1
Springfield 1
Tijuana 1
Tunis 1
Turku 1
Wroclaw 1
Wuhu 1
Totale 260
Nome #
Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps 122
Early increase in eosinophil count may predict long-term hypereosinophilia during dupilumab treatment: a 2-year observational study 104
Hypereosinophilia management in patients with type 2 chronic rhinosinusitis treated with dupilumab: preliminary results 102
The importance of clinical presentation on long-term outcomes of external dacryocystorhinostomies: Our experience on 245 cases 94
Comparison of guidelines for prescription and follow-up of biologics for chronic rhinosinusitis with nasal polyps 12
An adjoint-based approach for the surgical correction of nasal septal deviations 2
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL) 1
Totale 437
Categoria #
all - tutte 1.622
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.622


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202426 0 2 2 6 0 2 0 2 0 0 0 12
2024/202589 9 1 1 4 7 11 10 24 7 2 6 7
2025/2026322 23 19 11 42 56 18 23 27 90 13 0 0
Totale 437